IRIDEX Company Insiders
| IRIX Stock | USD 1.74 0.16 10.13% |
IRIDEX employs about 111 people. The company is managed by 5 executives with a total tenure of roughly 5 years, averaging almost 1.0 years of service per executive, having 22.2 employees per reported executive. Break down of IRIDEX's management performance can provide insight into the company performance.
| David Bruce CEO CEO President |
IRIDEX |
IRIDEX Management Team Effectiveness
The company has return on total asset (ROA) of (0.2089) % which means that it has lost $0.2089 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5028) %, meaning that it created substantial loss on money invested by shareholders. IRIDEX's management efficiency ratios could be used to measure how well IRIDEX manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.21 in 2024. Return On Capital Employed is likely to rise to -0.28 in 2024. At this time, IRIDEX's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.5 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.4 M in 2024.Common Stock Shares Outstanding is likely to drop to about 10.5 M in 2024. Net Loss is likely to rise to about (6.5 M) in 2024
IRIDEX Workforce Comparison
IRIDEX is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 5,506. IRIDEX holds roughly 111 in number of employees claiming about 2.02% of equities under Health Care industry.
IRIDEX Profit Margins
The company has Profit Margin (PM) of (0.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.51 |
|
|
IRIDEX Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRIDEX insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRIDEX's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, IRIDEX insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Patrick Mercer over a month ago Acquisition by Patrick Mercer of 200000 shares of IRIDEX subject to Rule 16b-3 | ||
Ludlum Ken over three months ago Acquisition by Ludlum Ken of 18348 shares of IRIDEX subject to Rule 16b-3 | ||
Patrick Mercer over three months ago Disposition of tradable shares by Patrick Mercer of IRIDEX at 7.67 subject to Rule 16b-3 | ||
Patrick Mercer over three months ago Disposition of 4123 shares by Patrick Mercer of IRIDEX at 2.16 subject to Rule 16b-3 | ||
Patrick Mercer over six months ago Acquisition by Patrick Mercer of 120000 shares of IRIDEX subject to Rule 16b-3 | ||
Patrick Mercer over six months ago Disposition of tradable shares by Patrick Mercer of IRIDEX at 2.67 subject to Rule 16b-3 | ||
Patrick Mercer over six months ago Disposition of tradable shares by Patrick Mercer of IRIDEX at 6.21 subject to Rule 16b-3 | ||
Scott Shuda over six months ago Acquisition by Scott Shuda of 267 shares of IRIDEX at 1.91 subject to Rule 16b-3 |
IRIDEX Notable Stakeholders
An IRIDEX stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IRIDEX often face trade-offs trying to please all of them. IRIDEX's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IRIDEX's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Bruce | CEO President | Profile | |
| Scott JD | Executive Chairman | Profile | |
| Leigh Salvo | Head Relations | Profile | |
| Patrick Mercer | Chief Officer | Profile | |
| Fuad Ahmad | Interim Officer | Profile |
About IRIDEX Management Performance
The success or failure of an entity such as IRIDEX often depends on how effective the management is. IRIDEX management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IRIDEX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IRIDEX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.21) | |
| Return On Capital Employed | (0.29) | (0.28) | |
| Return On Assets | (0.21) | (0.19) | |
| Return On Equity | (0.50) | (0.48) |
Please note, the imprecision that can be found in IRIDEX's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IRIDEX. Check IRIDEX's Beneish M Score to see the likelihood of IRIDEX's management manipulating its earnings.
IRIDEX Workforce Analysis
Traditionally, organizations such as IRIDEX use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare IRIDEX within its industry.IRIDEX Manpower Efficiency
Return on IRIDEX Manpower
| Revenue Per Employee | 467.3K | |
| Revenue Per Executive | 10.4M | |
| Net Loss Per Employee | 86.2K | |
| Net Loss Per Executive | 1.9M | |
| Working Capital Per Employee | 130.4K | |
| Working Capital Per Executive | 2.9M |
Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.